Anxiety During Pregnancy: What Every Expecting Parent Should Know

Perinatal refers to the period spanning pregnancy through the first year postpartum — not just the time after birth. Perinatal anxiety therefore includes anxiety that begins during pregnancy, not only after delivery.

This distinction matters because the conversation about perinatal mental health has historically centered on postpartum depression — leaving prenatal anxiety dramatically underrecognized. The data is striking: anxiety during pregnancy is more common than prenatal depression, affecting an estimated 15–20% of pregnancies. One in six pregnant people experiences clinically significant anxiety — yet routine OB/GYN appointments rarely screen for it with the same structure used for depression.

Part of why perinatal anxiety goes unrecognized: it gets absorbed into the general category of “pregnancy worry.” Providers and patients alike may assume some degree of worry is expected and therefore dismiss it. There's also a structural gap — OB/GYNs are trained to monitor physical health during pregnancy, and psychiatry is often consulted only when things escalate significantly.

It helps to distinguish between three presentations:

Generalized pregnancy worry — concern about the baby's health, birth going well, financial readiness. This is expected and proportionate. It comes and goes, doesn't dominate daily function, and doesn't generate significant physical symptoms.

Clinical perinatal anxiety — worry that is excessive, persistent, difficult to control, and interferes with sleep, functioning, or daily life. The concern feels out of proportion to the actual situation. It doesn't resolve with reassurance.

Prenatal OCD — involves intrusive thoughts, often about harm coming to the baby. These thoughts are ego-dystonic: the person experiencing them is horrified by the thought, not planning to act on it. A parent might have a sudden mental image of dropping the baby, or a thought about something terrible happening during delivery — and then feel profound shame and distress about having had the thought at all. Prenatal OCD is widely misunderstood. The intrusive thought itself is not a sign that someone is dangerous; it is a sign that OCD is present.

The presentation of anxiety during pregnancy can be physical, cognitive, or behavioral — and it often overlaps with normal pregnancy symptoms in ways that complicate recognition.

Physical symptoms

Insomnia (difficulty falling asleep or staying asleep), racing heart, muscle tension, tension headaches, and nausea. The nausea and sleep disruption can be particularly hard to disentangle from pregnancy itself — morning sickness is common in the first trimester, and sleep architecture changes throughout pregnancy. But anxiety-driven insomnia has a distinct quality: the person is lying awake thinking, not just physically uncomfortable.

Cognitive symptoms

Catastrophizing about birth complications, fixating on worst-case scenarios about the baby's health, excessive reassurance-seeking (repeated ultrasounds, Dr. Google spirals at midnight), difficulty concentrating, and pervasive worry about parenting ability. “What if something is wrong and the tests missed it?” “What if I'm not capable of doing this?” These thoughts are persistent and don't respond well to logical reassurance.

Prenatal OCD: what intrusive thoughts actually mean

Intrusive thoughts in prenatal OCD often involve vivid mental images or thoughts about the baby being harmed — during delivery, after birth, by the parent's own actions. The person experiencing these thoughts is not dangerous. They are distressed because the thoughts are contrary to everything they want. OCD is driven by the attempt to suppress or neutralize these thoughts — through avoidance, compulsive reassurance-seeking, or repetitive mental rituals. The anxiety is about the thought, not about any actual intent.

How it differs from “normal” pregnancy worry

The distinguishing features are frequency, intensity, and functional impairment. Normal worry comes and goes and doesn't consume daily life. Clinical anxiety is persistent, difficult to dismiss, and affects sleep, relationships, work, or the ability to prepare for the baby in any meaningful way.

Knowing the risk factors matters because they inform who might benefit from proactive monitoring and early support — rather than waiting until anxiety becomes severe before raising it with a provider.

• Prior anxiety or OCD history — the most significant predictor. Pre-existing anxiety disorders frequently intensify during pregnancy due to hormonal shifts and the psychological weight of a major life transition.
• History of pregnancy loss or infertility — anxiety after loss is almost universal. The clinical term “pregnancy after loss” captures a distinct experience where hypervigilance to signs of another loss can dominate the pregnancy.
• High-risk pregnancy — medical complications, prior preterm births, or conditions requiring close monitoring create objective reasons for concern that can escalate into clinical anxiety.
• Lack of social support — a partnered pregnancy with an involved, supportive partner carries meaningfully lower risk than a pregnancy experienced with social isolation, an absent partner, or an unsupportive family system.
• First pregnancy — the unfamiliarity of every sensation and every decision creates a higher ambient level of uncertainty, which anxiety feeds on.
• Hormonal fluctuations in the first trimester — the rapid shift in estrogen and progesterone during early pregnancy has direct neurobiological effects on mood regulation and anxiety circuitry. This is one reason anxiety often surfaces or intensifies in the first trimester, before the stressors of late pregnancy even begin.

This is the topic that generates the most fear, the most misinformation, and the most consequential decision-making errors. Let's be clear about what we actually know.

The FDA category system was retired in 2015

The old A/B/C/D/X pregnancy categories that labeled medications as “safe” or “unsafe” for pregnancy were replaced by the Pregnancy and Lactation Labeling Rule. The new labeling requires narrative risk summaries based on available human and animal data — because “Category C” was never actually a clinical recommendation. It was a placeholder. The current framework demands a risk-benefit analysis for each patient, not a categorical yes or no.

Untreated anxiety also carries fetal risks

This is the piece that often gets left out of the conversation: untreated severe anxiety during pregnancy is not a neutral alternative to medication. Chronic maternal stress elevates cortisol levels, which crosses the placenta. Elevated prenatal cortisol has been associated with preterm labor, low birth weight, and effects on fetal neurodevelopment. The question is never “medication vs. no risk” — it's “what is the risk-benefit of treatment compared to the risk of non-treatment for this specific person?”

SSRIs in pregnancy: sertraline and escitalopram

Sertraline (Zoloft) and escitalopram (Lexapro) are the most studied SSRIs in pregnancy and are among the most commonly prescribed. The data on both is extensive enough that the risk picture is reasonably well characterized — though not without nuance. No medication is zero-risk in pregnancy; neither is untreated anxiety or depression. The available data on sertraline in particular has not shown a consistent signal for major structural birth defects, and the overall risk is considered low relative to the benefit of treating moderate-to-severe anxiety or depression.

A persistent labeling note worth addressing: neonatal adaptation syndrome — transient symptoms (jitteriness, irritability, feeding difficulties) in newborns exposed to SSRIs near delivery. This is real, generally mild and self-resolving, and is part of the risk-benefit conversation. It is not a reason to automatically avoid SSRIs in the third trimester; it is a reason to have a plan.

Benzodiazepines: used sparingly

Benzodiazepines (lorazepam, clonazepam, alprazolam) are sometimes used during pregnancy for acute anxiety management — but they carry additional considerations, including the potential for neonatal adaptation syndrome (withdrawal-like symptoms in the newborn) and the need for careful monitoring. They are generally not the first-line treatment for chronic anxiety during pregnancy and are used most carefully in the third trimester.

Stopping cold turkey is NOT automatically safer

This is perhaps the most dangerous piece of misinformation in perinatal psychiatry. A pregnant person who is taking an SSRI for anxiety and stops abruptly upon learning they are pregnant — without consulting their prescriber — is not reducing risk. They are risking discontinuation syndrome (which can include severe anxiety, dizziness, and flu-like symptoms) and the rapid return of the underlying condition. Abrupt discontinuation is not safer than a medically supervised taper and a risk-benefit conversation.

Shared decision-making with OB and prescriber

Medication decisions during pregnancy should involve both the obstetric team and the prescriber — ideally in communication with each other. The OB monitors the pregnancy and can flag any concerns about fetal growth or delivery planning. The prescriber (whether a psychiatrist, PMHNP, or primary care provider) understands the psychiatric indication, the available data, and the risk of undertreatment. Neither can fully substitute for the other in this conversation.

For mild-to-moderate perinatal anxiety, several non-medication approaches have a meaningful evidence base. These are not substitutes for medication when medication is indicated — but they are effective stand-alone treatments for many people and valuable adjuncts for others.

Cognitive Behavioral Therapy (CBT)

CBT has the strongest evidence base for anxiety treatment across populations, and pregnancy-adapted CBT protocols exist specifically for perinatal anxiety and OCD. CBT works by identifying the thought patterns that maintain anxiety (catastrophizing, overestimating threat, underestimating coping capacity) and building concrete skills to respond differently. Unlike supportive therapy, CBT is structured and skills-based — it's particularly well-suited to anxiety because it targets the cognitive and behavioral mechanisms directly.

Mindfulness-Based Stress Reduction (MBSR)

The 8-week MBSR program developed by Jon Kabat-Zinn has been studied specifically in perinatal populations with promising results. MBSR teaches the ability to observe thoughts and sensations without reacting to them — which directly addresses the “I'm having this thought, therefore it must be true” quality of anxious cognition. Many hospitals now offer adapted perinatal mindfulness programs; online versions are also widely available.

Perinatal-specific therapy

Not all therapists are equally equipped to support perinatal mental health. A therapist who specializes in perinatal work will be familiar with the specific presentations of prenatal anxiety, prenatal OCD, the psychology of pregnancy after loss, and the transition to parenthood. Postpartum Support International (PSI) maintains a provider directory at postpartum.net — filtering by “pregnancy” or “perinatal” will identify providers with this specialty.

Partner and support system involvement

Partners who understand what perinatal anxiety looks like — and who know how to respond to it in helpful rather than dismissive ways — are a meaningful part of treatment. Phrases like “you're overthinking it” or “everything will be fine” are well-intentioned but tend to increase anxiety rather than reduce it. Psychoeducation for partners is valuable.

Sleep hygiene during pregnancy

Sleep disruption and anxiety are bidirectional during pregnancy — anxiety makes sleep harder; poor sleep amplifies anxiety. Sleep hygiene interventions (consistent schedule, reducing screen use before bed, managing physical discomfort with positioning aids) don't resolve clinical anxiety but they remove a significant amplifier. CBT for insomnia (CBT-I) has evidence specifically during pregnancy and is worth seeking out if sleep-onset anxiety is a primary complaint.

There's a real gap in how perinatal anxiety care is structured. OB/GYNs can screen and refer, but most are not equipped to manage psychiatric conditions directly. Prescribers — psychiatrists, psychiatric nurse practitioners, some primary care providers — are the right people to have the medication and comprehensive treatment conversation. Getting connected to the right part of the system early is the goal.

OB/GYN role vs. prescriber role

Your OB/GYN is the right first person to tell — they can screen formally, make referrals, and flag any pregnancy-specific considerations for a prescriber. But “your OB said it should be fine” is not a substitute for a prescriber-level risk-benefit conversation about specific medications and your specific history. These are complementary roles, not interchangeable ones.

How to bring it up

You don't need clinical language. A clear description of functional impact is enough:

“I've been having anxiety that's interfering with my sleep and daily functioning for [X weeks]. I'm not sure if it's within the normal range, but it feels like more than normal worry and I wanted to bring it up.”

That's enough to prompt a formal screening, a referral, or a treatment conversation. You do not need to convince your provider that your anxiety is real or severe enough to warrant attention.

Questions worth asking

• “What is the risk-benefit of treating versus not treating my anxiety during pregnancy?” This frames the conversation correctly — neither option is risk-free.
• “What would monitoring look like if I start or continue a medication?” Understand what follow-up care the plan involves.
• “What is the postpartum plan?” Anxiety during pregnancy significantly increases risk for postpartum anxiety. A plan for the postpartum period should be part of the perinatal mental health conversation, not an afterthought.

Before any prescriber appointment — whether for an existing medication or a new one — the free medication checklist covers the 5 questions worth asking before you start.